ANIDULAFUNGIN News
ANIDULAFUNGIN currently has 0 news articles, with 12 predicted indications.
This page combines the AI-predicted indications for ANIDULAFUNGIN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (12):
- esophageal candidiasis (99.0%)
- candidemia (99.0%)
- impetigo (98.8%)
- malignant pleural mesothelioma (98.8%)
- staphylococcal scalded skin syndrome (98.7%)
- pleural empyema (disease) (98.5%)
- malignant visceral pleura tumor (98.5%)
- bullous impetigo (98.4%)
- malignant epithelioid mesothelioma (98.4%)
- sarcomatoid mesothelioma (98.3%)
- hordeolum (98.2%)
- Clostridium infectious disease (98.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.